News | Breast Density | September 12, 2017

Video provides educational resource for underserved yet vulnerable population

DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts

September 12, 2017 – Breast cancer risks associated with fibroglandular breast density are the subject of a new Spanish language video launched recently by DenseBreast-info.org.

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death among Hispanic women, a population that is young and growing, yet underserved. During its initial posting on the DenseBreast-info Inc. Spanish language Facebook page, Información Senos Densos, the video garnered over 10,000 views in 72 hours. Currently it is also posted on the organization’s website and is being widely shared within Spanish-speaking communities.

Dense breasts contain a high proportion of glandular compared to fatty tissue. Density can mask cancers on mammography, leading to later-stage diagnoses. Research indicates that cancer detected at the earliest stage possible results in more positive outcomes. Therefore, understanding the implication of dense tissue is particularly important for this population segment. The six-and-a-half-minute video is a primer on breast density, its implications for cancer risk and screening, and appropriate supplemental screening tools.

Breast density notification laws are currently enacted in 30 states, encompassing 70 percent of American women. These laws require that some level of information about breast density be provided to women after their mammogram, but such notification can lead to questions. According to DenseBreast-info chief scientific advisor Wendie Berg, M.D., Ph.D., FACR, “Forty percent of women of mammography age have dense breasts. Breast density can compromise the effectiveness of a mammogram and screening tests such as ultrasound or MRI [magnetic resonance imaging], used in addition to mammography, substantially increase detection of early-stage breast cancer in dense breasts. Additionally, breast density increases a woman’s risk for the disease. Information about personal risk factors and breast cancer screening in dense breasts is important for all women. Patient content in Spanish broadens the reach of this educational resource.”

A Patient Brochure and Patient Risk Checklist are also available in Spanish on the organization’s website.

For more information: www.densebreast-info.org


Related Content

News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | Artificial Intelligence

Dec. 1, 2025 — Researchers at the University of California, Berkeley and University of California, San Francisco have ...

Time December 10, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now